David Walker-Sünderhauf

PhD student

David Sünderhauf is a PhD student investigating the use of CRISPR-Cas9 biotechnology to remove antibiotic resistance genes from bacterial communities.

This work is exploring how resistance genes can be removed from a range of diverse bacteria, stopping the widespread dispersal of antibiotic resistance within a bacterial community.

David is funded by the Medical Research Council, supervised by Professor Will Gaze, and is based at the Centre’s labs in Penryn.

He completed his undergraduate degree in immunology at the University of Aberdeen before moving to Cornwall to complete an MRes in bacterial evolutionary ecology.

You can also find David on the van Houte lab’s webpages.

 

Related content

Research project

Tackling antibiotic resistance using CRISPR

This project is investigating the use of CRISPR-Cas9 biotechnology to remove antibiotic resistance genes from bacterial communities.

News

Research is key weapon in tackling antibiotic resistance

Research at the European Centre for Environment  & Human Health is part of an unprecedented cross council collaboration to tackle the rising threat of antibiotic resistance. For the first time, all seven UK research councils have come together to co-ordinate the work of their teams.
Research project

What is the best way of delivering virtual nature for improving mood?

Exposure to ‘real’ nature can increase positive affect and decrease negative affect, but direct access is not always possible. For example for people in health/care settings who often experience chronic…